<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Ehlers-Danlos Syndrome, COL5A1-related - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Ehlers-Danlos Syndrome, COL5A1-related</span>
        </nav>

        <header class="page-header">
            <h1>Ehlers-Danlos Syndrome, COL5A1-related</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Genetic</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0007522" target="_blank">
                        MONDO:0007522
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Ehlers-Danlos Syndrome</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                A hereditary connective tissue disorder caused by pathogenic variants in the COL5A1 gene, which encodes the alpha-1 chain of type V collagen. This form accounts for approximately 50% of classic Ehlers-Danlos syndrome cases and is characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars, easy bruising, and generalized joint hypermobility. The disease follows autosomal dominant inheritance with variable expressivity.
            </p>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">11</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Collagen Type V Abnormalities</div>
                
                <div class="item-desc">Mutations in the COL5A1 gene lead to defective collagen type V synthesis and assembly.</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        collagen fibril organization
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030199" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        collagen biosynthetic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0032964" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9042913" target="_blank">PMID:9042913</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The mutation causes the substitution of the most 5&#39; cysteine residue by a serine within a highly conserved sequence of the pro(alpha)1(V) C-propeptide domain and causes reduction of collagen V by preventing incorporation of the mutant pro(alpha)1(V) chains in the collagen V trimers."</div>
                
                
                <div class="evidence-explanation">This reference describes how mutations in COL5A1 lead to defective synthesis and assembly of collagen type V, supporting the given statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Connective Tissue Fragility</div>
                
                <div class="item-desc">Abnormal collagen type V leads to weakened connective tissues throughout the body.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        fibroblast
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000057" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        dermal fibroblast
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0002620" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        extracellular matrix organization
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030198" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20847697" target="_blank">PMID:20847697</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In the majority of patients with molecularly characterized classic Ehlers-Danlos syndrome, the disease is caused by a mutation leading to a nonfunctional COL5A1 allele and resulting in haploinsufficiency of type V collagen."</div>
                
                
                <div class="evidence-explanation">The literature indicates that mutations in the COL5A1 gene lead to abnormalities in collagen type V, resulting in weakened connective tissues.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15095409" target="_blank">PMID:15095409</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"EDS cells with COL5A1 haplo-insufficiency deposited less than one-half of hydroxyproline as collagen compared to control fibroblasts. ... a reduction of type V collagen, in the EDS derived cells, was associated with the assembly of significantly fewer fibrils compared to control and OI cells."</div>
                
                
                <div class="evidence-explanation">This study demonstrates that reduced type V collagen results in weaker connective tissue due to a significant decrease in collagen fibril assembly.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12836217" target="_blank">PMID:12836217</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The classical form of the syndrome, which will be principally discussed in this review, can be due to mutations on collagen V, a fibrillar collagen present in small amounts in affected tissues."</div>
                
                
                <div class="evidence-explanation">The literature describes the role of collagen V and its mutations in causing connective tissue fragility, therefore supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Tissue Injury and Dysfunction</div>
                
                <div class="item-desc">Fragile tissues are prone to damage, leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing. Impaired wound healing involves altered mechanosensitive integrin signaling and defective re-epithelialization.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        keratinocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000312" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        wound healing
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0042060" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        signal transduction
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007165" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        integrin-mediated signaling pathway
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007229" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19370768" target="_blank">PMID:19370768</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Classical Ehlers-Danlos syndrome (EDS) is a heritable disorder characterized by joint hypermobility, skin hyperextensibility, and abnormal wound healing."</div>
                
                
                <div class="evidence-explanation">The provided literature directly supports the claim that Ehlers-Danlos Syndrome, particularly related to COL5A1, results in fragile tissues leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19592142" target="_blank">PMID:19592142</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The bleeding tendency is most prominent in the Ehlers-Danlos syndrome (EDS), a heterogeneous group of HDCT sharing clinical manifestations of fragility in skin, ligaments, blood vessels and internal organs."</div>
                
                
                <div class="evidence-explanation">The literature mentions fragility in tissues due to EDS, consistent with fragile tissues leading to manifestations such as joint dislocations and skin hyperextensibility.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20697718" target="_blank">PMID:20697718</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Ehlers-Danlos Syndrome is a term that comprises a variety of inherited connective tissue disorders characterized primarily by skin hyperextensibility, joints hypermobility and excessive dislocations, easy bruisability, generalized fragility."</div>
                
                
                <div class="evidence-explanation">The literature supports the claim, highlighting tissue fragility, joint hypermobility, and skin hyperextensibility as key characteristics.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">⬡</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph TD
    Chronic_Joint_Pain[&#34;Chronic Joint Pain&#34;]
    Joint_Hypermobility[&#34;Joint Hypermobility&#34;]
    Recurrent_Joint_Dislocations[&#34;Recurrent Joint Dislocations&#34;]

    Joint_Hypermobility --&gt; Recurrent_Joint_Dislocations
    Joint_Hypermobility --&gt; Chronic_Joint_Pain

    style Chronic_Joint_Pain fill:#fef3c7
    style Joint_Hypermobility fill:#fef3c7
    style Recurrent_Joint_Dislocations fill:#fef3c7</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">11</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Joint Hypermobility
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Musculoskeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001382" target="_blank">
                            HP:0001382
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                    
                    <span class="tag" style="background: #bbf7d0; color: #166534;">Recurrent Joint Dislocations</span>
                    
                    <span class="tag" style="background: #bbf7d0; color: #166534;">Chronic Joint Pain</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34807421" target="_blank">PMID:34807421</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Currently, musculoskeletal manifestations related to joint hypermobility are perceived as the most prevalent determinants of the quality of life of affected individuals."</div>
                
                
                <div class="evidence-explanation">This reference supports the high frequency and significant impact of joint hypermobility in Ehlers-Danlos syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19370768" target="_blank">PMID:19370768</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Classical Ehlers-Danlos syndrome (EDS) is a heritable disorder characterized by joint hypermobility, skin hyperextensibility, and abnormal wound healing."</div>
                
                
                <div class="evidence-explanation">The reference supports the musculoskeletal phenotype involving joint hypermobility and associated symptoms like joint pain.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35964930" target="_blank">PMID:35964930</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Classical (cEDS) and vascular type (vEDS) are the most prevalent subtypes and are caused by heterozygous pathogenic variants in COL5A1, COL5A2, COL1A1 or, respectively, in COL3A1."</div>
                
                
                <div class="evidence-explanation">This indicates a direct relationship between COL5A1 mutations and the classical EDS phenotype, which includes musculoskeletal manifestations such as joint hypermobility.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Skin Hyperextensibility
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Dermatologic</span>
                    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20847697" target="_blank">PMID:20847697</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin..."</div>
                
                
                <div class="evidence-explanation">The abstract clearly states that skin hyperextensibility is a primary feature of classic Ehlers-Danlos syndrome, which is often caused by COL5A1 mutations.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36764582" target="_blank">PMID:36764582</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A high prevalence of skin hyperextensibility, bruising, and soft skin were noted."</div>
                
                
                <div class="evidence-explanation">Skin hyperextensibility is identified as a common feature in Ehlers-Danlos syndromes, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37594181" target="_blank">PMID:37594181</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The classic tragic facial expression was observed as well as chronic pruritus and mild hyperesthesia."</div>
                
                
                <div class="evidence-explanation">This reference supports the dermatologic phenotype of Ehlers-Danlos Syndrome, including traits commonly associated with COL5A1 mutations.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Atrophic Scarring
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Dermatologic</span>
                    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20847697" target="_blank">PMID:20847697</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars."</div>
                
                
                <div class="evidence-explanation">The literature specifies that classic Ehlers-Danlos syndrome, which includes COL5A1-related cases, involves the formation of atrophic scars as a common dermatologic phenotype.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Easy Bruising
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Dermatologic</span>
                    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20847697" target="_blank">PMID:20847697</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by ... easy bruising."</div>
                
                
                <div class="evidence-explanation">This reference confirms the presence of easy bruising as a common phenotype of classic Ehlers-Danlos syndrome, which is often related to COL5A1 mutations.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36764582" target="_blank">PMID:36764582</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The Ehlers-Danlos syndromes (EDSs) comprise a group of connective tissue disorders that manifest with... easy bruising..."</div>
                
                
                <div class="evidence-explanation">This source supports that easy bruising is a common dermatologic manifestation in Ehlers-Danlos syndromes, which includes types related to COL5A1 mutations.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15566352" target="_blank">PMID:15566352</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Easy bruising is, to a variable degree, present in all subtypes of EDS..."</div>
                
                
                <div class="evidence-explanation">This excerpt indicates that easy bruising is a common feature across various subtypes of Ehlers-Danlos syndrome, which would include the COL5A1-related types.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Mitral Valve Prolapse
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Cardiovascular</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001634" target="_blank">
                            HP:0001634
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21193204" target="_blank">PMID:21193204</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Fifteen of the 252 patients (6.0%) had mitral valve prolapse (MVP), although only one patient (0.4%) had MVP that was mild to moderate."</div>
                
                
                <div class="evidence-explanation">The literature shows an occasional incidence of mitral valve prolapse in Ehlers-Danlos Syndrome, and while the exact subtype related to COL5A1 is not specified, it partially supports the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34776077" target="_blank">PMID:34776077</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The EDS are currently classified into thirteen subtypes. There is substantial symptoms overlap between the EDS subtypes, and they are associated with an increased incidence of cardiovascular abnormalities, such as mitral valve prolapse and aortic dissection."</div>
                
                
                <div class="evidence-explanation">This reference supports the association of Ehlers-Danlos Syndrome (a group including COL5A1-related subtypes) with mitral valve prolapse.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Gastroesophageal Reflux
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Gastrointestinal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002020" target="_blank">
                            HP:0002020
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26376608" target="_blank">PMID:26376608</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Commonest GI symptoms were: abdominal pain (56.1%), nausea (42.3%), constipation (38.6%), heartburn (37.6%), and irritable bowel syndrome-like symptoms (27.5%)... Among 37.8% of the 378 patients who underwent esophagogastroduodenoscopy, the commonest abnormalities were gastritis, hiatal hernia..."</div>
                
                
                <div class="evidence-explanation">The study indicates that reflux esophagitis, which is related to gastroesophageal reflux, is one of the common abnormalities observed in EDS patients. However, it does not explicitly distinguish the frequency of this phenotype for COL5A1-related EDS specifically.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Molluscoid Pseudotumors
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Dermatologic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0000993" target="_blank">
                            HP:0000993
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27905128" target="_blank">PMID:27905128</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Molluscoid pseudotumours are a characteristic finding in patients with the classic ED variant, but are rarely reported in other variants."</div>
                
                
                <div class="evidence-explanation">The literature confirms that molluscoid pseudotumors are characteristic of the classic variant of Ehlers-Danlos Syndrome, which can be COL5A1-related. This supports the statement that these dermatologic features can occur occasionally in such cases.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Myopia
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Ocular</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0000545" target="_blank">
                            HP:0000545
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36237549" target="_blank">PMID:36237549</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In addition to these commonly recognized phenotypes, recent studies have notably highlighted variable ophthalmic features in EDS."</div>
                
                
                <div class="evidence-explanation">The study mentions variable ophthalmic features in EDS but does not specifically mention myopia as an occasional feature related to COL5A1.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30246406" target="_blank">PMID:30246406</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The affected cat showed multiple recurrent skin tears, hyperextensibility of the skin and joint abnormalities."</div>
                
                
                <div class="evidence-explanation">The study on a cat with EDS caused by a COL5A1 mutation does not mention myopia.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Recurrent Joint Dislocations
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Musculoskeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001373" target="_blank">
                            HP:0001373
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20697718" target="_blank">PMID:20697718</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Ehlers-Danlos Syndrome is a term that comprises a variety of inherited connective tissue disorders characterized primarily by skin hyperextensibility, joints hypermobility and excessive dislocations, easy bruisability, generalized fragility."</div>
                
                
                <div class="evidence-explanation">The literature supports excessive dislocations as a characteristic feature of Ehlers-Danlos Syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Chronic Joint Pain
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Musculoskeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002829" target="_blank">
                            HP:0002829
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/10906878" target="_blank">PMID:10906878</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Thirty patients with Type III Ehlers-Danlos syndrome reported joint pain more frequently than did patients with Types I, II, or IV."</div>
                
                
                <div class="evidence-explanation">The literature supports chronic joint pain as a frequent symptom in Ehlers-Danlos syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Delayed Wound Healing
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Dermatologic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001030" target="_blank">
                            HP:0001030
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20847697" target="_blank">PMID:20847697</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars."</div>
                
                
                <div class="evidence-explanation">Delayed wound healing is a core feature of classic EDS due to defective collagen V.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    COL5A1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                <div class="item-meta">
                    
                    <span class="tag" style="background: #bfdbfe; color: #1e40af;">Autosomal Dominant</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30858776" target="_blank">PMID:30858776</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Among all tested patients, nine mutations of COL5A1 gene were detected (8 missense mutations and 1 splice site)."</div>
                
                
                <div class="evidence-explanation">This reference confirms the existence of missense and splice site mutations in the COL5A1 gene among Ehlers-Danlos Syndrome patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33656776" target="_blank">PMID:33656776</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Glycine substitution mutation of COL5A1 in classic Ehlers-Danlos syndrome: a case report and literature review."</div>
                
                
                <div class="evidence-explanation">This reference supports the presence of missense mutations specifically related to COL5A1 in Ehlers-Danlos Syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35241120" target="_blank">PMID:35241120</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This study supports that rs12722 is associated with an elevated susceptibility to ligament injury, especially in the Caucasian population."</div>
                
                
                <div class="evidence-explanation">While the study primarily investigates the association of COL5A1 polymorphisms with musculoskeletal injuries, it partially supports the statement by recognizing relevant genetic variants.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Supportive Care
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000011" target="_blank">
                            MAXO:0000011
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Management of pain, physical therapy to strengthen joints, and prevention of complications.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22616833" target="_blank">PMID:22616833</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The topics addressed in this issue are Ehlers-Danlos syndrome and associated chronic pain; the information is meant to help readers understand the mechanisms for pain in this connective tissue disorder as well as general treatment principles for chronic pain management."</div>
                
                
                <div class="evidence-explanation">The reference discusses chronic pain management in the context of Ehlers-Danlos syndrome, aligning with the statement about management of pain.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33741806" target="_blank">PMID:33741806</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Evidence supporting physical therapy and occupational therapy is provided... Treatment should be individualized."</div>
                
                
                <div class="evidence-explanation">The reference discusses the role of physical therapy in the management of hypermobile Ehlers-Danlos syndromes (hEDS), which aligns with the statement about physical therapy to strengthen joints.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9042913" target="_blank">PMID:9042913</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"These findings confirm the causal role of collagen V in at least a subgroup of EDS I."</div>
                
                
                <div class="evidence-explanation">The reference focuses on the genetic aspect and causal mutations in COL5A1 related to Ehlers-Danlos syndrome but does not delve into treatments.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Wound Care
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Careful attention to wound healing and scar management.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8274350" target="_blank">PMID:8274350</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Manifestations are highly variable, and include numerous skin abnormalities. Nurses play an important role in helping patients and their families live with this unusual disorder."</div>
                
                
                <div class="evidence-explanation">The reference mentions skin abnormalities but does not provide explicit details on treatments related to wound care or scar management.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2728341" target="_blank">PMID:2728341</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Although delayed wound healing has been reported to be a complication of Ehlers-Danlos syndrome in humans, using clinical and histologic criteria, wound healing in dogs and cats with Ehlers-Danlos syndrome appears to be similar to nonaffected animals."</div>
                
                
                <div class="evidence-explanation">This reference discusses wound healing in animal models of EDS but indicates that delayed healing, a common complication in human EDS patients, was not observed in the studied animals.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28387435" target="_blank">PMID:28387435</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Classic Ehlers-Danlos syndrome (EDS) patients suffer from connective tissue hyperelasticity, joint instability, skin hyperextensibility, tissue fragility, and poor wound healing due to heterozygous mutations in COL5a1 or COL5a2 genes."</div>
                
                
                <div class="evidence-explanation">This reference identifies poor wound healing as a complication associated with classic EDS due to COL5A1 mutations, which supports the need for careful attention to wound healing and scar management.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Cardiovascular Monitoring
                    
                </div>
                
                <div class="item-desc">Regular evaluation for mitral valve prolapse and other cardiovascular complications.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21193204" target="_blank">PMID:21193204</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Echocardiography may still be warranted as part of cardiovascular assessment, but decreased frequency of screening is recommended especially in symptom-free adults."</div>
                
                
                <div class="evidence-explanation">This reference supports cardiovascular monitoring in Ehlers-Danlos Syndrome, particularly for mitral valve prolapse and aortic dilation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15607555" target="_blank">PMID:15607555</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This proposal is specifically concerned with Ehlers-Danlos syndrome classic type (formerly Types I-III), which is characterized by ... cardiac mitral valve prolapse."</div>
                
                
                <div class="evidence-explanation">This reference supports the need for evaluation in Ehlers-Danlos Syndrome for cardiovascular complications like mitral valve prolapse.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Gastrointestinal Management
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000267" target="_blank">
                            MAXO:0000267
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Treatment of gastroesophageal reflux and other GI symptoms as needed.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26376608" target="_blank">PMID:26376608</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"CONCLUSIONS &amp; INFERENCES: EDS HM and other subtypes should be considered in patients with chronic functional GI symptoms and abdominal vascular lesions."</div>
                
                
                <div class="evidence-explanation">This study highlights the prevalence of gastrointestinal manifestations in patients with various subtypes of EDS, indicating that GI management, including treatment of conditions like gastroesophageal reflux, is indeed a necessary part of the overall treatment plan.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Lifestyle Modifications
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000088" target="_blank">
                            MAXO:0000088
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Avoiding high-impact activities and contact sports to prevent injury, and using protective gear when necessary.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17067502" target="_blank">PMID:17067502</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Preparticipation cardiothoracic and orthopedic screening is highly recommended for athletes with EDS, and appropriate cardiovascular, orthopedic, gastrointestinal, neurologic, and dermatologic management can often allow patients with EDS to remain active."</div>
                
                
                <div class="evidence-explanation">The literature emphasizes careful screening and multidisciplinary management for athletes with EDS, which implicitly supports the avoidance of high-impact activities to prevent injuries but does not explicitly mention the use of protective gear or contact sports.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32899328" target="_blank">PMID:32899328</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The major clinical manifestations of EDS include joint hypermobility, skin hyperextensibility, and generalized connective tissue fragility. ... These findings allow healthcare providers to know more about this disease in order to support and give advice to patients about the changes they will..."</div>
                
                
                <div class="evidence-explanation">The study highlights the importance of providing advice to patients about lifestyle changes due to EDS but does not specifically mention avoiding high-impact activities or using protective gear.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Physical Trauma</div>
                
                
                <div class="item-desc">External mechanical forces including falls, impacts, and repetitive strain that stress the weakened connective tissue.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26452443" target="_blank">PMID:26452443</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Ehlers-Danlos syndrome remains undetected until the patient, usually in the pediatric age, shows extensive or severe mucocutaneous injuries after only minor traumas."</div>
                
                
                <div class="evidence-explanation">The reference suggests that minor physical trauma can cause severe injuries in patients with Ehlers-Danlos syndrome, which implies an exacerbation of symptoms; however, it does not directly address COL5A1-related cases specifically.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34740257" target="_blank">PMID:34740257</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Haploinsufficiency of the Col5a1 gene encoding alpha(1) chain of type V collagen is the primary cause of classic Ehlers-Danlos syndrome."</div>
                
                
                <div class="evidence-explanation">While the article primarily discusses the genetic cause and molecular mechanisms, it indicates that the structural abnormalities in the extracellular matrix due to COL5A1 deficiency may contribute to symptom exacerbation following physical trauma. However, it does not directly state that physical trauma exacerbates symptoms.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36405827" target="_blank">PMID:36405827</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Compromised brain tissues and cerebrovasculature could leave these patients vulnerable to mild traumatic brain injury (TBI), with increased severity and duration of post-concussive symptoms and delayed recovery."</div>
                
                
                <div class="evidence-explanation">The reference discusses increased vulnerability to traumatic brain injury and severe post-concussive symptoms in presumed Ehlers-Danlos syndrome patients, supporting the notion that physical trauma exacerbates symptoms.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Collagen Type V
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased or Abnormal)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21697718" target="_blank">PMID:21697718</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We have shown that a variant within COL5A1, which encodes a subunit of type V collagen, is associated with injury and performance phenotypes. Although seemingly unrelated, these phenotypes are associated directly or indirectly with the mechanical properties of musculoskeletal soft tissue."</div>
                
                
                <div class="evidence-explanation">The literature indicates that the variants in COL5A1 can impact the mechanical properties of the tissue, suggesting an alteration in collagen type V structure.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33189937" target="_blank">PMID:33189937</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Functional assays demonstrated a significant decrease of collagen alpha1(V) chain expression in both heterozygous parents compared to control cells, and an additive effect of these two variants in the proband."</div>
                
                
                <div class="evidence-explanation">The decrease in collagen alpha1(V) chain expression indicates a biochemical abnormality.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20979576" target="_blank">PMID:20979576</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mutations in COL5A1 or COL5A2, encoding respectively the alpha1(V)- and alpha2(V)-collagen chain, cause classic EDS (Ehlers-Danlos syndrome)."</div>
                
                
                <div class="evidence-explanation">The article talks about mutations in COL5A1 leading to classical EDS, suggesting the defects in collagen type V.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Ehlers-Danlos Syndrome, COL5A1-related
description: &gt;-
  A hereditary connective tissue disorder caused by pathogenic variants in the COL5A1 gene,
  which encodes the alpha-1 chain of type V collagen. This form accounts for approximately
  50% of classic Ehlers-Danlos syndrome cases and is characterized by skin hyperextensibility,
  fragile and soft skin, delayed wound healing with formation of atrophic scars, easy
  bruising, and generalized joint hypermobility. The disease follows autosomal dominant
  inheritance with variable expressivity.
category: Genetic
parents:
- Ehlers-Danlos Syndrome
prevalence:
- population: Global
  percentage: 0.002-0.01
  evidence:
  - reference: PMID:20847697
    supports: PARTIAL
    snippet: It is currently estimated that approximately 50% of patients with a clinical
      diagnosis of classic Ehlers-Danlos syndrome harbor mutations in the COL5A1 and
      the COL5A2 gene.
    explanation: This reference indicates that COL5A1-related EDS is a subset of classic
      EDS, making up about 50% of classic EDS cases. However, it does not provide
      specific global prevalence rates of COL5A1-related EDS.
progression:
- phase: Onset
  age_range: Birth-20
  evidence:
  - reference: PMID:20847697
    supports: PARTIAL
    snippet: Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder
      characterized by skin hyperextensibility, fragile and soft skin, delayed wound
      healing with formation of atrophic scars, easy bruising, and generalized joint
      hypermobility.
    explanation: While the COL5A1-related Ehlers-Danlos Syndrome (classic type) is
      described as a heritable connective tissue disorder with certain clinical features
      observable from birth, the literature does not specifically detail the age range
      for the onset of symptoms as &#39;Birth-20&#39;.
pathophysiology:
- name: Collagen Type V Abnormalities
  description: Mutations in the COL5A1 gene lead to defective collagen type V synthesis
    and assembly.
  biological_processes:
  - preferred_term: collagen fibril organization
    term:
      id: GO:0030199
      label: collagen fibril organization
  - preferred_term: collagen biosynthetic process
    term:
      id: GO:0032964
      label: collagen biosynthetic process
  evidence:
  - reference: PMID:9042913
    supports: SUPPORT
    snippet: The mutation causes the substitution of the most 5&#39; cysteine residue
      by a serine within a highly conserved sequence of the pro(alpha)1(V) C-propeptide
      domain and causes reduction of collagen V by preventing incorporation of the
      mutant pro(alpha)1(V) chains in the collagen V trimers.
    explanation: This reference describes how mutations in COL5A1 lead to defective
      synthesis and assembly of collagen type V, supporting the given statement.
- name: Connective Tissue Fragility
  description: Abnormal collagen type V leads to weakened connective tissues throughout
    the body.
  cell_types:
  - preferred_term: fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  - preferred_term: dermal fibroblast
    term:
      id: CL:0002620
      label: skin fibroblast
  biological_processes:
  - preferred_term: extracellular matrix organization
    term:
      id: GO:0030198
      label: extracellular matrix organization
  cellular_components:
  - preferred_term: extracellular matrix
    term:
      id: GO:0031012
      label: extracellular matrix
  evidence:
  - reference: PMID:20847697
    supports: SUPPORT
    snippet: In the majority of patients with molecularly characterized classic Ehlers-Danlos
      syndrome, the disease is caused by a mutation leading to a nonfunctional COL5A1
      allele and resulting in haploinsufficiency of type V collagen.
    explanation: The literature indicates that mutations in the COL5A1 gene lead to
      abnormalities in collagen type V, resulting in weakened connective tissues.
  - reference: PMID:15095409
    supports: SUPPORT
    snippet: EDS cells with COL5A1 haplo-insufficiency deposited less than one-half
      of hydroxyproline as collagen compared to control fibroblasts. ... a reduction
      of type V collagen, in the EDS derived cells, was associated with the assembly
      of significantly fewer fibrils compared to control and OI cells.
    explanation: This study demonstrates that reduced type V collagen results in weaker
      connective tissue due to a significant decrease in collagen fibril assembly.
  - reference: PMID:12836217
    supports: SUPPORT
    snippet: The classical form of the syndrome, which will be principally discussed
      in this review, can be due to mutations on collagen V, a fibrillar collagen
      present in small amounts in affected tissues.
    explanation: The literature describes the role of collagen V and its mutations
      in causing connective tissue fragility, therefore supporting the statement.
- name: Tissue Injury and Dysfunction
  description: Fragile tissues are prone to damage, leading to manifestations like
    joint dislocations, skin hyperextensibility, and poor wound healing. Impaired
    wound healing involves altered mechanosensitive integrin signaling and defective
    re-epithelialization.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  locations:
  - preferred_term: skin of body
    term:
      id: UBERON:0002097
      label: skin of body
  - preferred_term: tendon
    term:
      id: UBERON:0000043
      label: tendon
  - preferred_term: corneal stroma
    term:
      id: UBERON:0001772
      label: corneal stroma
  biological_processes:
  - preferred_term: wound healing
    term:
      id: GO:0042060
      label: wound healing
  - preferred_term: signal transduction
    term:
      id: GO:0007165
      label: signal transduction
  - preferred_term: integrin-mediated signaling pathway
    term:
      id: GO:0007229
      label: integrin-mediated signaling pathway
  cellular_components:
  - preferred_term: pericellular matrix
    term:
      id: GO:0036046
      label: pericellular matrix
  evidence:
  - reference: PMID:19370768
    supports: SUPPORT
    snippet: Classical Ehlers-Danlos syndrome (EDS) is a heritable disorder characterized
      by joint hypermobility, skin hyperextensibility, and abnormal wound healing.
    explanation: The provided literature directly supports the claim that Ehlers-Danlos
      Syndrome, particularly related to COL5A1, results in fragile tissues leading
      to manifestations like joint dislocations, skin hyperextensibility, and poor
      wound healing.
  - reference: PMID:19592142
    supports: SUPPORT
    snippet: The bleeding tendency is most prominent in the Ehlers-Danlos syndrome
      (EDS), a heterogeneous group of HDCT sharing clinical manifestations of fragility
      in skin, ligaments, blood vessels and internal organs.
    explanation: The literature mentions fragility in tissues due to EDS, consistent
      with fragile tissues leading to manifestations such as joint dislocations and
      skin hyperextensibility.
  - reference: PMID:20697718
    supports: SUPPORT
    snippet: Ehlers-Danlos Syndrome is a term that comprises a variety of inherited
      connective tissue disorders characterized primarily by skin hyperextensibility,
      joints hypermobility and excessive dislocations, easy bruisability, generalized
      fragility.
    explanation: The literature supports the claim, highlighting tissue fragility,
      joint hypermobility, and skin hyperextensibility as key characteristics.
  - reference: PMID:19055167
    supports: SUPPORT
    snippet: Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective tissue
      disorders characterized by hyperextensibility, delayed wound healing, joint
      hypermobility, thin skin, easy bruising, tissue fragility, &#39;cigarette-paper&#39;
      scarring over bony prominences.
    explanation: This reference supports the claim, describing characteristics that
      align with tissue fragility and symptoms such as joint dislocations, skin hyperextensibility,
      and poor wound healing.
phenotypes:
- category: Musculoskeletal
  name: Joint Hypermobility
  description: Abnormally increased range of motion in multiple joints due to lax connective tissue.
  frequency: VERY_FREQUENT
  diagnostic: true
  sequelae:
  - target: Recurrent Joint Dislocations
    description: Joint hypermobility predisposes to repeated episodes of joint displacement.
  - target: Chronic Joint Pain
    description: Persistent joint pain resulting from joint instability and repeated subluxations.
  evidence:
  - reference: PMID:34807421
    supports: SUPPORT
    snippet: Currently, musculoskeletal manifestations related to joint hypermobility
      are perceived as the most prevalent determinants of the quality of life of affected
      individuals.
    explanation: This reference supports the high frequency and significant impact
      of joint hypermobility in Ehlers-Danlos syndrome.
  - reference: PMID:19370768
    supports: SUPPORT
    snippet: Classical Ehlers-Danlos syndrome (EDS) is a heritable disorder characterized
      by joint hypermobility, skin hyperextensibility, and abnormal wound healing.
    explanation: The reference supports the musculoskeletal phenotype involving joint
      hypermobility and associated symptoms like joint pain.
  - reference: PMID:35964930
    supports: SUPPORT
    snippet: Classical (cEDS) and vascular type (vEDS) are the most prevalent subtypes
      and are caused by heterozygous pathogenic variants in COL5A1, COL5A2, COL1A1
      or, respectively, in COL3A1.
    explanation: This indicates a direct relationship between COL5A1 mutations and
      the classical EDS phenotype, which includes musculoskeletal manifestations such
      as joint hypermobility.
  - reference: PMID:10906878
    supports: SUPPORT
    snippet: Thirty patients with Type III Ehlers-Danlos syndrome reported joint pain
      more frequently than did patients with Types I, II, or IV.
    explanation: This supports the involvement of recurrent joint dislocations and
      chronic joint pain in the EDS phenotype.
  phenotype_term:
    preferred_term: Joint Hypermobility
    term:
      id: HP:0001382
      label: Joint hypermobility
- category: Dermatologic
  name: Skin Hyperextensibility
  description: Skin that can be stretched beyond the normal range and returns to its original position when released.
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:20847697
    supports: SUPPORT
    snippet: Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder
      characterized by skin hyperextensibility, fragile and soft skin...
    explanation: The abstract clearly states that skin hyperextensibility is a primary
      feature of classic Ehlers-Danlos syndrome, which is often caused by COL5A1 mutations.
  - reference: PMID:36764582
    supports: SUPPORT
    snippet: A high prevalence of skin hyperextensibility, bruising, and soft skin
      were noted.
    explanation: Skin hyperextensibility is identified as a common feature in Ehlers-Danlos
      syndromes, supporting the statement.
  - reference: PMID:37594181
    supports: SUPPORT
    snippet: The classic tragic facial expression was observed as well as chronic
      pruritus and mild hyperesthesia.
    explanation: This reference supports the dermatologic phenotype of Ehlers-Danlos
      Syndrome, including traits commonly associated with COL5A1 mutations.
- category: Dermatologic
  name: Atrophic Scarring
  description: Formation of thin, widened scars with a papyraceous or cigarette-paper appearance, typically over bony prominences.
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:20847697
    supports: SUPPORT
    snippet: Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder
      characterized by skin hyperextensibility, fragile and soft skin, delayed wound
      healing with formation of atrophic scars.
    explanation: The literature specifies that classic Ehlers-Danlos syndrome, which
      includes COL5A1-related cases, involves the formation of atrophic scars as a
      common dermatologic phenotype.
- category: Dermatologic
  name: Easy Bruising
  description: Increased susceptibility to bruising from minor trauma due to fragile blood vessels and connective tissue.
  frequency: FREQUENT
  evidence:
  - reference: PMID:20847697
    supports: SUPPORT
    snippet: Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder
      characterized by ... easy bruising.
    explanation: This reference confirms the presence of easy bruising as a common
      phenotype of classic Ehlers-Danlos syndrome, which is often related to COL5A1
      mutations.
  - reference: PMID:36764582
    supports: SUPPORT
    snippet: The Ehlers-Danlos syndromes (EDSs) comprise a group of connective tissue
      disorders that manifest with... easy bruising...
    explanation: This source supports that easy bruising is a common dermatologic
      manifestation in Ehlers-Danlos syndromes, which includes types related to COL5A1
      mutations.
  - reference: PMID:15566352
    supports: SUPPORT
    snippet: Easy bruising is, to a variable degree, present in all subtypes of EDS...
    explanation: This excerpt indicates that easy bruising is a common feature across
      various subtypes of Ehlers-Danlos syndrome, which would include the COL5A1-related
      types.
- category: Cardiovascular
  name: Mitral Valve Prolapse
  description: Abnormal bulging of the mitral valve leaflets into the left atrium during systole due to connective tissue laxity.
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:21193204
    supports: PARTIAL
    snippet: Fifteen of the 252 patients (6.0%) had mitral valve prolapse (MVP), although
      only one patient (0.4%) had MVP that was mild to moderate.
    explanation: The literature shows an occasional incidence of mitral valve prolapse
      in Ehlers-Danlos Syndrome, and while the exact subtype related to COL5A1 is
      not specified, it partially supports the statement.
  - reference: PMID:34776077
    supports: SUPPORT
    snippet: The EDS are currently classified into thirteen subtypes. There is substantial
      symptoms overlap between the EDS subtypes, and they are associated with an increased
      incidence of cardiovascular abnormalities, such as mitral valve prolapse and
      aortic dissection.
    explanation: This reference supports the association of Ehlers-Danlos Syndrome
      (a group including COL5A1-related subtypes) with mitral valve prolapse.
  phenotype_term:
    preferred_term: Mitral Valve Prolapse
    term:
      id: HP:0001634
      label: Mitral valve prolapse
- category: Gastrointestinal
  name: Gastroesophageal Reflux
  description: Backflow of stomach contents into the esophagus, possibly related to laxity of the lower esophageal sphincter.
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:26376608
    supports: PARTIAL
    snippet: &#39;Commonest GI symptoms were: abdominal pain (56.1%), nausea (42.3%),
      constipation (38.6%), heartburn (37.6%), and irritable bowel syndrome-like symptoms
      (27.5%)... Among 37.8% of the 378 patients who underwent esophagogastroduodenoscopy,
      the commonest abnormalities were gastritis, hiatal hernia and reflux esophagitis.&#39;
    explanation: The study indicates that reflux esophagitis, which is related to
      gastroesophageal reflux, is one of the common abnormalities observed in EDS
      patients. However, it does not explicitly distinguish the frequency of this
      phenotype for COL5A1-related EDS specifically.
  phenotype_term:
    preferred_term: Gastroesophageal Reflux
    term:
      id: HP:0002020
      label: Gastroesophageal reflux
- category: Dermatologic
  name: Molluscoid Pseudotumors
  description: Fleshy, scar-associated lesions that develop over pressure points and areas of repeated trauma.
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:27905128
    supports: SUPPORT
    snippet: Molluscoid pseudotumours are a characteristic finding in patients with
      the classic ED variant, but are rarely reported in other variants.
    explanation: The literature confirms that molluscoid pseudotumors are characteristic
      of the classic variant of Ehlers-Danlos Syndrome, which can be COL5A1-related.
      This supports the statement that these dermatologic features can occur occasionally
      in such cases.
  phenotype_term:
    preferred_term: Molluscoid Pseudotumors
    term:
      id: HP:0000993
      label: Molluscoid pseudotumors
- category: Ocular
  name: Myopia
  description: Nearsightedness, a refractive error where distant objects appear blurred.
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:36237549
    supports: PARTIAL
    snippet: In addition to these commonly recognized phenotypes, recent studies have
      notably highlighted variable ophthalmic features in EDS.
    explanation: The study mentions variable ophthalmic features in EDS but does not
      specifically mention myopia as an occasional feature related to COL5A1.
  - reference: PMID:30246406
    supports: NO_EVIDENCE
    snippet: The affected cat showed multiple recurrent skin tears, hyperextensibility
      of the skin and joint abnormalities.
    explanation: The study on a cat with EDS caused by a COL5A1 mutation does not
      mention myopia.
  phenotype_term:
    preferred_term: Myopia
    term:
      id: HP:0000545
      label: Myopia
- category: Musculoskeletal
  name: Recurrent Joint Dislocations
  description: Repeated episodes of joints becoming displaced from their normal positions.
  frequency: FREQUENT
  evidence:
  - reference: PMID:20697718
    supports: SUPPORT
    snippet: Ehlers-Danlos Syndrome is a term that comprises a variety of inherited
      connective tissue disorders characterized primarily by skin hyperextensibility,
      joints hypermobility and excessive dislocations, easy bruisability, generalized
      fragility.
    explanation: The literature supports excessive dislocations as a characteristic
      feature of Ehlers-Danlos Syndrome.
  phenotype_term:
    preferred_term: Recurrent Joint Dislocations
    term:
      id: HP:0001373
      label: Joint dislocation
- category: Musculoskeletal
  name: Chronic Joint Pain
  description: Persistent pain in multiple joints resulting from joint instability, subluxations, and degenerative changes.
  frequency: FREQUENT
  evidence:
  - reference: PMID:10906878
    supports: SUPPORT
    snippet: Thirty patients with Type III Ehlers-Danlos syndrome reported joint pain
      more frequently than did patients with Types I, II, or IV.
    explanation: The literature supports chronic joint pain as a frequent symptom
      in Ehlers-Danlos syndrome.
  phenotype_term:
    preferred_term: Chronic Joint Pain
    term:
      id: HP:0002829
      label: Arthralgia
- category: Dermatologic
  name: Delayed Wound Healing
  description: Prolonged time for wounds to heal with impaired re-epithelialization and abnormal granulation tissue formation.
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:20847697
    supports: SUPPORT
    snippet: Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder
      characterized by skin hyperextensibility, fragile and soft skin, delayed wound
      healing with formation of atrophic scars.
    explanation: Delayed wound healing is a core feature of classic EDS due to defective
      collagen V.
  phenotype_term:
    preferred_term: Delayed Wound Healing
    term:
      id: HP:0001030
      label: Fragile skin
biochemical:
- name: Collagen Type V
  presence: Decreased or Abnormal
  evidence:
  - reference: PMID:21697718
    supports: SUPPORT
    snippet: We have shown that a variant within COL5A1, which encodes a subunit of
      type V collagen, is associated with injury and performance phenotypes. Although
      seemingly unrelated, these phenotypes are associated directly or indirectly
      with the mechanical properties of musculoskeletal soft tissue.
    explanation: The literature indicates that the variants in COL5A1 can impact the
      mechanical properties of the tissue, suggesting an alteration in collagen type
      V structure.
  - reference: PMID:33189937
    supports: SUPPORT
    snippet: Functional assays demonstrated a significant decrease of collagen alpha1(V)
      chain expression in both heterozygous parents compared to control cells, and
      an additive effect of these two variants in the proband.
    explanation: The decrease in collagen alpha1(V) chain expression indicates a biochemical
      abnormality.
  - reference: PMID:20979576
    supports: SUPPORT
    snippet: Mutations in COL5A1 or COL5A2, encoding respectively the alpha1(V)- and
      alpha2(V)-collagen chain, cause classic EDS (Ehlers-Danlos syndrome).
    explanation: The article talks about mutations in COL5A1 leading to classical
      EDS, suggesting the defects in collagen type V.
  - reference: PMID:15095409
    supports: SUPPORT
    snippet: EDS cells with COL5A1 haplo-insufficiency deposited less than one-half
      of hydroxyproline as collagen compared to control fibroblasts, though total
      collagen synthesis rates are near-normal because type V collagen represents
      a small fraction of collagen synthesized.
    explanation: The deposition of collagen is significantly reduced in EDS cells
      with COL5A1 haplo-insufficiency, clearly indicating a biochemical abnormality
      in collagen type V.
genetic:
- name: COL5A1
  association: Pathogenic Variants
  inheritance:
  - name: Autosomal Dominant
    description: A single pathogenic variant inherited from one parent is sufficient to cause disease; most cases are inherited, though de novo mutations occur.
  variants:
  - name: Missense Mutations
    description: Single nucleotide changes resulting in altered amino acid sequence.
  - name: Splice Site Mutations
    description: Changes affecting mRNA splicing and leading to exon skipping or intronic
      retention.
  - name: Frameshift Mutations
    description: Insertions or deletions causing a shift in the reading frame and
      often resulting in a premature stop codon.
  evidence:
  - reference: PMID:30858776
    supports: SUPPORT
    snippet: Among all tested patients, nine mutations of COL5A1 gene were detected
      (8 missense mutations and 1 splice site).
    explanation: This reference confirms the existence of missense and splice site
      mutations in the COL5A1 gene among Ehlers-Danlos Syndrome patients.
  - reference: PMID:33656776
    supports: SUPPORT
    snippet: &#39;Glycine substitution mutation of COL5A1 in classic Ehlers-Danlos syndrome:
      a case report and literature review.&#39;
    explanation: This reference supports the presence of missense mutations specifically
      related to COL5A1 in Ehlers-Danlos Syndrome.
  - reference: PMID:35241120
    supports: PARTIAL
    snippet: This study supports that rs12722 is associated with an elevated susceptibility
      to ligament injury, especially in the Caucasian population.
    explanation: While the study primarily investigates the association of COL5A1
      polymorphisms with musculoskeletal injuries, it partially supports the statement
      by recognizing relevant genetic variants.
  - reference: PMID:2683783
    supports: WRONG_STATEMENT
    snippet: Mutations in the majority of the 20 known collagen genes have not yet
      been identified.
    explanation: This reference doesn&#39;t support the existence of frameshift mutations
      in COL5A1, making the specific part of the statement regarding frameshift mutations
      unsubstantiated.
environmental:
- name: Physical Trauma
  description: External mechanical forces including falls, impacts, and repetitive strain that stress the weakened connective tissue.
  effect: Exacerbates Symptoms
  evidence:
  - reference: PMID:26452443
    supports: PARTIAL
    snippet: Ehlers-Danlos syndrome remains undetected until the patient, usually
      in the pediatric age, shows extensive or severe mucocutaneous injuries after
      only minor traumas.
    explanation: The reference suggests that minor physical trauma can cause severe
      injuries in patients with Ehlers-Danlos syndrome, which implies an exacerbation
      of symptoms; however, it does not directly address COL5A1-related cases specifically.
  - reference: PMID:34740257
    supports: PARTIAL
    snippet: Haploinsufficiency of the Col5a1 gene encoding alpha(1) chain of type
      V collagen is the primary cause of classic Ehlers-Danlos syndrome.
    explanation: While the article primarily discusses the genetic cause and molecular
      mechanisms, it indicates that the structural abnormalities in the extracellular
      matrix due to COL5A1 deficiency may contribute to symptom exacerbation following
      physical trauma. However, it does not directly state that physical trauma exacerbates
      symptoms.
  - reference: PMID:36405827
    supports: SUPPORT
    snippet: Compromised brain tissues and cerebrovasculature could leave these patients
      vulnerable to mild traumatic brain injury (TBI), with increased severity and
      duration of post-concussive symptoms and delayed recovery.
    explanation: The reference discusses increased vulnerability to traumatic brain
      injury and severe post-concussive symptoms in presumed Ehlers-Danlos syndrome
      patients, supporting the notion that physical trauma exacerbates symptoms.
treatments:
- name: Supportive Care
  description: Management of pain, physical therapy to strengthen joints, and prevention
    of complications.
  evidence:
  - reference: PMID:22616833
    supports: SUPPORT
    snippet: The topics addressed in this issue are Ehlers-Danlos syndrome and associated
      chronic pain; the information is meant to help readers understand the mechanisms
      for pain in this connective tissue disorder as well as general treatment principles
      for chronic pain management.
    explanation: The reference discusses chronic pain management in the context of
      Ehlers-Danlos syndrome, aligning with the statement about management of pain.
  - reference: PMID:33741806
    supports: SUPPORT
    snippet: Evidence supporting physical therapy and occupational therapy is provided...
      Treatment should be individualized.
    explanation: The reference discusses the role of physical therapy in the management
      of hypermobile Ehlers-Danlos syndromes (hEDS), which aligns with the statement
      about physical therapy to strengthen joints.
  - reference: PMID:9042913
    supports: NO_EVIDENCE
    snippet: These findings confirm the causal role of collagen V in at least a subgroup
      of EDS I.
    explanation: The reference focuses on the genetic aspect and causal mutations
      in COL5A1 related to Ehlers-Danlos syndrome but does not delve into treatments.
  - reference: PMID:35162892
    supports: NO_EVIDENCE
    snippet: Treatment is currently symptomatic and focuses on increasing the quality
      of life of these patients, as there is no curative treatment.
    explanation: The reference mentions symptomatic treatment but does not provide
      specific details on pain management, physical therapy, or prevention of complications
      for COL5A1-related Ehlers-Danlos syndrome.
  - reference: PMID:32941194
    supports: NO_EVIDENCE
    snippet: Although medical interventions to help halt the disease progression remain
      limited, improved awareness of vEDS by patients and practitioners have resulted
      in increased average life expectancy.
    explanation: The reference discusses limited medical interventions and management
      of vascular Ehlers-Danlos syndrome (vEDS), which is different from COL5A1-related
      EDS.
  treatment_term:
    preferred_term: physical therapy
    term:
      id: MAXO:0000011
      label: physical therapy
- name: Wound Care
  description: Careful attention to wound healing and scar management.
  evidence:
  - reference: PMID:8274350
    supports: PARTIAL
    snippet: Manifestations are highly variable, and include numerous skin abnormalities.
      Nurses play an important role in helping patients and their families live with
      this unusual disorder.
    explanation: The reference mentions skin abnormalities but does not provide explicit
      details on treatments related to wound care or scar management.
  - reference: PMID:2728341
    supports: PARTIAL
    snippet: Although delayed wound healing has been reported to be a complication
      of Ehlers-Danlos syndrome in humans, using clinical and histologic criteria,
      wound healing in dogs and cats with Ehlers-Danlos syndrome appears to be similar
      to nonaffected animals.
    explanation: This reference discusses wound healing in animal models of EDS but
      indicates that delayed healing, a common complication in human EDS patients,
      was not observed in the studied animals.
  - reference: PMID:28387435
    supports: SUPPORT
    snippet: Classic Ehlers-Danlos syndrome (EDS) patients suffer from connective
      tissue hyperelasticity, joint instability, skin hyperextensibility, tissue fragility,
      and poor wound healing due to heterozygous mutations in COL5a1 or COL5a2 genes.
    explanation: This reference identifies poor wound healing as a complication associated
      with classic EDS due to COL5A1 mutations, which supports the need for careful
      attention to wound healing and scar management.
  - reference: PMID:37594181
    supports: SUPPORT
    snippet: The classic tragic facial expression was observed as well as chronic
      pruritus and mild hyperesthesia. ... Histology showed sparse, disorganized collagen
      and an increase in cutaneous mast cells. Electron microscopy identified ultrastructural
      defects commonly seen in collagen type V alpha 1 chain (COL5A1) variants including
      flower-like collagen fibrils in cross-section.
    explanation: This detailed observation of classic EDS symptoms and associated
      collagen abnormalities highlights the importance of wound and scar care in patients.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
- name: Cardiovascular Monitoring
  description: Regular evaluation for mitral valve prolapse and other cardiovascular
    complications.
  evidence:
  - reference: PMID:21193204
    supports: SUPPORT
    snippet: Echocardiography may still be warranted as part of cardiovascular assessment,
      but decreased frequency of screening is recommended especially in symptom-free
      adults.
    explanation: This reference supports cardiovascular monitoring in Ehlers-Danlos
      Syndrome, particularly for mitral valve prolapse and aortic dilation.
  - reference: PMID:15607555
    supports: SUPPORT
    snippet: This proposal is specifically concerned with Ehlers-Danlos syndrome classic
      type (formerly Types I-III), which is characterized by ... cardiac mitral valve
      prolapse.
    explanation: This reference supports the need for evaluation in Ehlers-Danlos
      Syndrome for cardiovascular complications like mitral valve prolapse.
- name: Gastrointestinal Management
  description: Treatment of gastroesophageal reflux and other GI symptoms as needed.
  evidence:
  - reference: PMID:26376608
    supports: SUPPORT
    snippet: &#39;CONCLUSIONS &amp; INFERENCES: EDS HM and other subtypes should be considered
      in patients with chronic functional GI symptoms and abdominal vascular lesions.&#39;
    explanation: This study highlights the prevalence of gastrointestinal manifestations
      in patients with various subtypes of EDS, indicating that GI management, including
      treatment of conditions like gastroesophageal reflux, is indeed a necessary
      part of the overall treatment plan.
  treatment_term:
    preferred_term: gastrointestinal agent therapy
    term:
      id: MAXO:0000267
      label: gastrointestinal agent therapy
- name: Lifestyle Modifications
  description: Avoiding high-impact activities and contact sports to prevent injury,
    and using protective gear when necessary.
  evidence:
  - reference: PMID:17067502
    supports: PARTIAL
    snippet: Preparticipation cardiothoracic and orthopedic screening is highly recommended
      for athletes with EDS, and appropriate cardiovascular, orthopedic, gastrointestinal,
      neurologic, and dermatologic management can often allow patients with EDS to
      remain active.
    explanation: The literature emphasizes careful screening and multidisciplinary
      management for athletes with EDS, which implicitly supports the avoidance of
      high-impact activities to prevent injuries but does not explicitly mention the
      use of protective gear or contact sports.
  - reference: PMID:32899328
    supports: PARTIAL
    snippet: The major clinical manifestations of EDS include joint hypermobility,
      skin hyperextensibility, and generalized connective tissue fragility. ... These
      findings allow healthcare providers to know more about this disease in order
      to support and give advice to patients about the changes they will have to make.
    explanation: The study highlights the importance of providing advice to patients
      about lifestyle changes due to EDS but does not specifically mention avoiding
      high-impact activities or using protective gear.
  treatment_term:
    preferred_term: dietary intervention
    term:
      id: MAXO:0000088
      label: dietary intervention
disease_term:
  preferred_term: classic Ehlers-Danlos syndrome
  term:
    id: MONDO:0007522
    label: Ehlers-Danlos syndrome, classic type
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Ehlers-Danlos_Syndrome_COL5A1-related.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>